Nectar Lifesciences Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 ('PIT Regulations')'.
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences Limited has submitted a disclosure to the Exchange as required under Regulation 7(2) of the SEBI PIT Regulations. This regulation mandates that insiders (such as promoters, directors, or key managerial personnel) report any trading in the company's securities that crosses the prescribed threshold (typically cumulative trading value of ₹10 lakh or more in a quarter). The specific details of the trade — including who traded, whether it was a buy or sell, and the quantity — are not visible from the headline alone. Shareholders should check the full filing on the NSE/BSE portal for exact transaction details.
PIT Regulation 7(2) disclosures are routine compliance filings and do not, by themselves, signal any negative or positive event. The actual market impact depends on whether the insider was buying (a confidence signal) or selling (potential caution signal).